No adverse reactions to the vaccine were noted, and study results showed that fewer than 2% of the weanlings exhibited clinical signs of EPE, much less than the 10% anticipated by the researchers.

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In